Varda Space and Orbital Pharm test cancer drugs in orbit today
Varda Space Industries and Orbital Pharm launched a spacecraft from Cape Canaveral, Florida, to test new cancer drug crystals in microgravity.
Spacecraft launches with experimental payload
The W-7 spacecraft lifted off on a SpaceX Falcon 9 rocket carrying the pharmaceutical experiment. Orbital Pharm and Varda Space Industries initiated this mission to examine how reduced gravity affects drug formation. The primary goal involves creating unique crystals that dissolve better in the human body.
Microgravity improves crystal structure
Michael Reilly, chief strategy officer for Varda, stated that space conditions allow compounds to solidify without disruptive convection processes. This method aims to produce superior dissolution properties for the innovative cancer treatments being developed. The resulting crystals could make the medicines more effective and potentially safer for patients.
Commercial scale remains distant
Developing medicines in space is currently a significant move, though commercial production on that scale is still a long-term goal. The mission also includes separate hypersonic testing and data gathering alongside the pharmaceutical experiments. Rapid delivery capabilities between Earth locations or orbit are being highlighted by recent SpaceX Starfall capsule tests.
Reported by one outlet
Only one outlet has published this. Nothing here has been checked against a second report, so read it as that outlet's account and follow the link below for the original.
Reported by
1 independent outlet. Headline as published. Links open the original report.